InvestorsHub Logo
Followers 4
Posts 702
Boards Moderated 0
Alias Born 05/19/2016

Re: None

Sunday, 07/23/2017 7:52:17 PM

Sunday, July 23, 2017 7:52:17 PM

Post# of 471362
Clearly, 2-73 has broad applications across a spectrum of CNS disorders. It's applications seem quite far-reaching. Distinguished scientists with reputations to protect are freely associating themselves publicly with this compound and company. Anavex is going to destroy the competition in this space within the next few years.

Imagine the world 10 years from now. Quite possibly several disorders which have no meaningful treatment could be made much more manageable or possibly reversed. And who knows how many other successes will be had in the next decade. Fun to think about.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News